Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
One-A-Day Women's is a comprehensive multivitamin and mineral dietary supplement developed and marketed by Bayer. It is specifically formulated to support the nutritional needs of women, targeting key areas such as bone health, immune function, skin health, heart health, and energy metabolism. The product contains a blend of essential vitamins (A, B6, B12, C, D, E, and K) and minerals (iron, calcium, zinc, selenium, chromium, copper, and manganese), along with other nutrients like folic acid and biotin. As a dietary supplement, it is intended to prevent or treat nutrient deficiencies resulting from poor diet or certain health conditions, rather than to diagnose, treat, or cure specific diseases. The formulation provides micronutrients that serve as essential cofactors for enzymatic reactions and ligands for nuclear receptors involved in systemic physiological maintenance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on One-A-Day Women's.